Andelyn Biosciences
Columbus, OH
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-29
65.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (20)
○ EMA GMP
○ MHRA GMP
Quick Facts: Andelyn Biosciences
- Signal Score
- 65.5/100 (as of 2026-04-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Columbus, OH
- Website
- https://andelynbio.com
- Modalities
- AAV, Lentiviral, Plasmid DNA
- Active Programs
- No ClinicalTrials.gov matches confirmed — 10 partnership announcements in press
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Andelyn Biosciences
Spinout from Nationwide Children's.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 10 partnership announcements found in press monitoring.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Plasmid DNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Partnership Announcements (from press monitoring)
Financial Stability
68.0
Parent company: Nationwide Children's Hospital spinout
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Nationwide Children's Hospital spinout
Financial assessment: 68.0/100
Capacity
63.0
Strong partnership activity (13 articles)
Sites: Columbus, OH
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
StatusAvailable
Strong partnership activity (13 articles)
Sites: Columbus, OH
Recent Press20 articles
Strong partnership activity (13 articles)
Recent News 20 articles
Andelyn Biosciences Targets Gene Therapy Growth Opportunities at ASGCT Meeting - TipRanks
Andelyn Biosciences Targets Gene Therapy Growth Opportunities at ASGCT Meeting TipRanks
ENCell signs partnership with U.S. CGT CDMO Andelyn Biosciences to build integrated production network - 더바이오
ENCell signs partnership with U.S. CGT CDMO Andelyn Biosciences to build integrated production network 더바이오
Andelyn Biosciences Emphasizes Gene and Cell Therapy Focus on National DNA Day - TipRanks
Andelyn Biosciences Emphasizes Gene and Cell Therapy Focus on National DNA Day TipRanks
Andelyn Biosciences Highlights Engagement at Gene Therapy Symposium - TipRanks
Andelyn Biosciences Highlights Engagement at Gene Therapy Symposium TipRanks
Andelyn Biosciences Expands Global Gene Therapy Reach and Showcases Digital CDMO Capabilities - TipRanks
Andelyn Biosciences Expands Global Gene Therapy Reach and Showcases Digital CDMO Capabilities TipRanks
Andelyn Biosciences Emphasizes Gene and Cell Therapy Focus on National DNA Day - TipRanks
Andelyn Biosciences Emphasizes Gene and Cell Therapy Focus on National DNA Day TipRanks
Andelyn Biosciences Highlights Presence at Gene Therapy Symposium - TipRanks
Andelyn Biosciences Highlights Presence at Gene Therapy Symposium TipRanks
Andelyn Biosciences Highlights Transparency-Focused Dashboard for Gene Therapy CDMO Clients - TipRanks
Andelyn Biosciences Highlights Transparency-Focused Dashboard for Gene Therapy CDMO Clients TipRanks
Andelyn Biosciences, ENCell Enter Strategic Gene Therapy Manufacturing Pact - Contract Pharma
Andelyn Biosciences, ENCell Enter Strategic Gene Therapy Manufacturing Pact Contract Pharma
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing - BioSpectrum Asia
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing BioSpectrum Asia
ENCell, Andelyn Biosciences partner to build global gene therapy production network - koreabiomed.com
ENCell, Andelyn Biosciences partner to build global gene therapy production network koreabiomed.com
Andelyn Partners with S. Korea-Based ENCell to Accelerate Global Delivery of Gene Therapies - Genetic Engineering and Biotechnology News
Andelyn Partners with S. Korea-Based ENCell to Accelerate Global Delivery of Gene Therapies Genetic Engineering and Biotechnology News
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing - BioSpectrum Asia
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing BioSpectrum Asia
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing - BioSpectrum Asia
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing BioSpectrum Asia
ENCell, Andelyn Biosciences partner to build global gene therapy production network - koreabiomed.com
ENCell, Andelyn Biosciences partner to build global gene therapy production network koreabiomed.com
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing - PR Newswire
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing PR Newswire
Andelyn Biosciences Sets Up US–APAC Manufacturing Bridge Through ENCell Partnership - TipRanks
Andelyn Biosciences Sets Up US–APAC Manufacturing Bridge Through ENCell Partnership TipRanks
Andelyn Biosciences Forms U.S.–APAC Gene Therapy Manufacturing Partnership With ENCell - TipRanks
Andelyn Biosciences Forms U.S.–APAC Gene Therapy Manufacturing Partnership With ENCell TipRanks
Andelyn Biosciences Partners with Evolyra Therapeutics for the Clinical Manufacturing of Gene Therapies for the Treatment of Limb-Girdle Muscular Dystrophies - PR Newswire
Andelyn Biosciences Partners with Evolyra Therapeutics for the Clinical Manufacturing of Gene Therapies for the Treatment of Limb-Girdle Muscular Dystrophies PR Newswire
Andelyn Biosciences to Manufacture Evolyra’s LGMD Gene Therapies Using AAV Curator Platform - TipRanks
Andelyn Biosciences to Manufacture Evolyra’s LGMD Gene Therapies Using AAV Curator Platform TipRanks
Frequently Asked Questions About Andelyn Biosciences
What is Andelyn Biosciences's CDMO Signal Score?
Andelyn Biosciences has a Signal Score of 66/100, based on quality, operations, financial stability, and capacity data.
Evaluating Andelyn Biosciences for a manufacturing program?
Use the free AI matchmaker to compare Andelyn Biosciences against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 83.1
AAV, Lentiviral, Plasmid DNA, Adenoviral
Oxford Biomedica
Oxford, United Kingdom
Signal Score: 77.1
Lentiviral, AAV, Plasmid DNA
CoJourney Inc.
Ambler, PA (US operations; primary manufacturing in Hangzhou, Zhejiang, China)
Signal Score: 60.0
Plasmid DNA, AAV, Adenoviral, Lentiviral, Retroviral, mRNA, sgRNA, Exosome
3P Biopharmaceuticals (now 3PBIOVIAN)
Pamplona-Noáin, Spain
Biologics (microbial & mammalian), AAV, Adenoviral, Lentiviral, Cell Therapy, Plasmid DNA, Recombinant Proteins, Biosimilars, Fill/Finish (recombinant proteins & viral vectors)
Rose BioSolutions
Rockville, MD
Plasmid DNA, AAV, Lentiviral, Adenoviral, CAR-T, Cell Therapy, Gene Editing, Cell Solutions / Starting Materials